Company news

Verrica Pharmaceuticals Inc. news in 2020

Verrica Pharmaceuticals Inc.'s news releases, calls and decks from 2020, newest first.

View company

Verrica Pharmaceuticals Announces Receipt of Final FDA Minutes Following Type A Meeting Regarding Resubmission of the NDA for VP-102 in Molluscum

November 16, 2020

Verrica Pharmaceuticals Announces Participation in the Jefferies Virtual London Healthcare Conference

November 11, 2020

Verrica Pharmaceuticals Announces Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with External Genital Warts (CARE-1)

November 9, 2020

Verrica Pharmaceuticals Reports Third Quarter 2020 Financial Results

November 8, 2020

Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 22nd Annual Global Investment Conference

September 8, 2020

Verrica Pharmaceuticals Licenses LTX-315, A First-in-Class Oncolytic Peptide Based Immunotherapy, from Lytix Biopharma AS, for the Treatment of Dermatologic Oncology Indications

August 10, 2020

Verrica Pharmaceuticals Reports Second Quarter 2020 Financial Results

August 4, 2020

Verrica Pharmaceuticals Announces Option Agreement with Torii Pharmaceutical to Develop & Commercialize VP-102 in Japan

August 4, 2020

Verrica Pharmaceuticals Announces Dr. Lawrence Eichenfield Joins Board of Directors

July 22, 2020

Verrica Pharmaceuticals Announces Clinical and Drug Development Leadership Changes

July 22, 2020

Verrica Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum

July 13, 2020

Verrica Pharmaceuticals Provides Regulatory Update on VP-102

June 28, 2020

Verrica Pharmaceuticals Announces Positive Results from Two New Pooled Analyses of the Phase 3 CAMP Trials of VP-102 in Molluscum Contagiosum

June 11, 2020

Verrica Pharmaceuticals Appoints Diem Nguyen, Ph.D., M.B.A., to its Board of Directors

June 9, 2020

Verrica Pharmaceuticals Reports First Quarter 2020 Financial Results

May 6, 2020

Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results

March 12, 2020

Verrica Pharmaceuticals Announces the Hiring of Two Vice Presidents to Further Grow its Commercial Capabilities

January 28, 2020

Verrica Pharmaceuticals Announces Presentation of Positive Data from New Pooled Analysis of Phase 3 CAMP Trials of VP-102

January 17, 2020

Decks in 2020